Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruqi Tang

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
American Journal of Human Genetics|December 13, 2006
Functional variants in the promoter region of Chitinase 3-like 1 (CHI3L1) and susceptibility to schizophreniaXinzhi Zhao, Ruqi Tang, Bo Gao, et al.
Clinical Reviews in Allergy & Immunology|June 3, 2022
Serum Biomarkers for Autoimmune Hepatitis Type 1: the Case for CD48 and a Review of the LiteratureMingli Hu, Zhengrui You, You Li, et al.
Journal of Hepatology|June 26, 2022
NUDT1 promotes the accumulation and longevity of CD103<sup>+</sup> T<sub>RM</sub> cells in primary biliary cholangitisBingyuan Huang, Zhuwan Lyu, Qiwei Qian, et al.
Hepatology Communications|December 11, 2021
MutT Homolog 1 Inhibitor Karonudib Attenuates Autoimmune Hepatitis by Inhibiting DNA Repair in Activated T CellsYong Chen, Xiangwei Hua, Bingyuan Huang, et al.
Med (New York, N.Y.)|September 21, 2024
Gut microbiome pattern impacts treatment response in primary biliary cholangitisQiaoyan Liu, Bingyuan Huang, Yijun Zhou, et al.
Cell Metabolism|October 11, 2024
Hepatic FXR-FGF4 is required for bile acid homeostasis via an FGFR4-LRH-1 signal node under cholestatic stressLintao Song, Yushu Hou, Da Xu, et al.
Gut|May 26, 2021
Altered faecal microbiome and metabolome in IgG4-related sclerosing cholangitis and primary sclerosing cholangitisQiaoyan Liu, Bo Li, Yikang Li, et al.
Journal of Autoimmunity|February 1, 2024
Immunosuppression induces regression of fibrosis in primary biliary cholangitis with moderate-to-severe interface hepatitisRui Wang, Qiuxiang Lin, Zhonghua Lu, et al.
Journal of Autoimmunity|February 3, 2019
Histologically proven AMA positive primary biliary cholangitis but normal serum alkaline phosphatase: Is alkaline phosphatase truly a surrogate marker?Chunyan Sun, Xiao Xiao, Li Yan, et al.
JHEP Reports : Innovation in Hepatology|August 18, 2025
Recompensation in patients with autoimmune hepatitis-related decompensated cirrhosis following immunosuppressive therapyYu Chen, Haoyu Wen, You Li, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
American Journal of Human Genetics|December 13, 2006
Functional variants in the promoter region of Chitinase 3-like 1 (CHI3L1) and susceptibility to schizophreniaXinzhi Zhao, Ruqi Tang, Bo Gao, et al.
Clinical Reviews in Allergy & Immunology|June 3, 2022
Serum Biomarkers for Autoimmune Hepatitis Type 1: the Case for CD48 and a Review of the LiteratureMingli Hu, Zhengrui You, You Li, et al.
Journal of Hepatology|June 26, 2022
NUDT1 promotes the accumulation and longevity of CD103<sup>+</sup> T<sub>RM</sub> cells in primary biliary cholangitisBingyuan Huang, Zhuwan Lyu, Qiwei Qian, et al.
Hepatology Communications|December 11, 2021
MutT Homolog 1 Inhibitor Karonudib Attenuates Autoimmune Hepatitis by Inhibiting DNA Repair in Activated T CellsYong Chen, Xiangwei Hua, Bingyuan Huang, et al.
Med (New York, N.Y.)|September 21, 2024
Gut microbiome pattern impacts treatment response in primary biliary cholangitisQiaoyan Liu, Bingyuan Huang, Yijun Zhou, et al.
Cell Metabolism|October 11, 2024
Hepatic FXR-FGF4 is required for bile acid homeostasis via an FGFR4-LRH-1 signal node under cholestatic stressLintao Song, Yushu Hou, Da Xu, et al.
Gut|May 26, 2021
Altered faecal microbiome and metabolome in IgG4-related sclerosing cholangitis and primary sclerosing cholangitisQiaoyan Liu, Bo Li, Yikang Li, et al.
Journal of Autoimmunity|February 1, 2024
Immunosuppression induces regression of fibrosis in primary biliary cholangitis with moderate-to-severe interface hepatitisRui Wang, Qiuxiang Lin, Zhonghua Lu, et al.
Journal of Autoimmunity|February 3, 2019
Histologically proven AMA positive primary biliary cholangitis but normal serum alkaline phosphatase: Is alkaline phosphatase truly a surrogate marker?Chunyan Sun, Xiao Xiao, Li Yan, et al.
JHEP Reports : Innovation in Hepatology|August 18, 2025
Recompensation in patients with autoimmune hepatitis-related decompensated cirrhosis following immunosuppressive therapyYu Chen, Haoyu Wen, You Li, et al.
Pageof 9